McKesson Ventures has returned to back a $40m round for Lightship, having co-led a $20m series B last year.
US-based clinical trial services provider Lightship obtained $40m in a funding round on Wednesday that included McKesson Ventures, the corporate venture capital unit of pharmaceuticals distributor McKesson. Define Ventures and private investor Brook Byers co-led the round, while Khosla Ventures and Time Ventures also took part. Founded in 2018, Lightship operates an end-to-end service to…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.